09:12 AM EDT, 04/18/2024 (MT Newswires) -- Health care stocks were mixed pre-bell Thursday, with the iShares Biotechnology ETF ( IBB ) down 0.1% and the Health Care Select Sector SPDR Fund (XLV) 0.4% higher.

Elevance Health ( ELV ) stock was up more than 2% after the company reported higher Q1 adjusted earnings and revenue in addition to lifting its fiscal 2024 non-GAAP earnings outlook.

Cerevel Therapeutics ( CERE ) shares were nearly 1% higher after the company said a phase 3 study of its investigational drug tavapadon, which is intended for the treatment of Parkinson's disease has met its primary endpoint.

Biohaven ( BHVN ) stock was down nearly 3% after the company said it priced an underwritten public offering of about 5.6 million shares at $41 each for gross proceeds of about $230 million.